238 related articles for article (PubMed ID: 31669893)
41. Fish oil protects the liver from parenteral nutrition-induced injury via GPR120-mediated PPARγ signaling.
Fell GL; Cho BS; Dao DT; Anez-Bustillos L; Baker MA; Nandivada P; Pan A; O'Loughlin AA; Mitchell PD; Nose V; Gura KM; Puder M
Prostaglandins Leukot Essent Fatty Acids; 2019 Apr; 143():8-14. PubMed ID: 30975380
[TBL] [Abstract][Full Text] [Related]
42. Methionine infusion reproduces liver injury of parenteral nutrition cholestasis.
Moss RL; Haynes AL; Pastuszyn A; Glew RH
Pediatr Res; 1999 May; 45(5 Pt 1):664-8. PubMed ID: 10231861
[TBL] [Abstract][Full Text] [Related]
43. Pantoprazole-induced autoimmune chronic hepatitis.
Meunier L; Ursic-Bedoya J; Pageaux GP; Larrey D
Liver Int; 2018 Jun; 38(6):995-999. PubMed ID: 29532602
[TBL] [Abstract][Full Text] [Related]
44. Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury.
Zen Y; Yeh MM
Mod Pathol; 2018 Jun; 31(6):965-973. PubMed ID: 29403081
[TBL] [Abstract][Full Text] [Related]
45. Liver complications of pediatric parenteral nutrition--epidemiology.
Kelly DA
Nutrition; 1998 Jan; 14(1):153-7. PubMed ID: 9437702
[TBL] [Abstract][Full Text] [Related]
46. Hepatic complications of total parenteral nutrition.
Baker AL; Rosenberg IH
Am J Med; 1987 Mar; 82(3):489-97. PubMed ID: 3103440
[TBL] [Abstract][Full Text] [Related]
47. Cholestasis in association with short-term parenteral alimentation.
Brown RS
Crit Care Med; 1976; 4(6):313-6. PubMed ID: 830073
[TBL] [Abstract][Full Text] [Related]
48. Intestinal failure-associated liver disease: what do we know today?
Kelly DA
Gastroenterology; 2006 Feb; 130(2 Suppl 1):S70-7. PubMed ID: 16473076
[TBL] [Abstract][Full Text] [Related]
49. Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets.
Van Aerde JE; Duerksen DR; Gramlich L; Meddings JB; Chan G; Thomson AB; Clandinin MT
Pediatr Res; 1999 Feb; 45(2):202-8. PubMed ID: 10022591
[TBL] [Abstract][Full Text] [Related]
50. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
[TBL] [Abstract][Full Text] [Related]
51. Clinical approach to the management of Intestinal Failure Associated Liver Disease (IFALD) in adults: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN.
Lal S; Pironi L; Wanten G; Arends J; Bozzetti F; Cuerda C; Joly F; Kelly D; Staun M; Szczepanek K; Van Gossum A; Schneider SM;
Clin Nutr; 2018 Dec; 37(6 Pt A):1794-1797. PubMed ID: 30017241
[TBL] [Abstract][Full Text] [Related]
52. Hepatic complications of parenteral nutrition.
Bower RH
Semin Liver Dis; 1983 Aug; 3(3):216-24. PubMed ID: 6414087
[TBL] [Abstract][Full Text] [Related]
53. Total parenteral nutrition and cholestasis.
Sandhu IS; Jarvis C; Everson GT
Clin Liver Dis; 1999 Aug; 3(3):489-508, viii. PubMed ID: 11291236
[TBL] [Abstract][Full Text] [Related]
54. Histopathological challenges in suspected drug-induced liver injury.
Kleiner DE
Liver Int; 2018 Feb; 38(2):198-209. PubMed ID: 28865179
[TBL] [Abstract][Full Text] [Related]
55. Hepatic fibrosis persists and progresses despite biochemical improvement in children treated with intravenous fish oil emulsion.
Mercer DF; Hobson BD; Fischer RT; Talmon GA; Perry DA; Gerhardt BK; Grant WJ; Botha JF; Langnas AN; Quiros-Tejeira RE
J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):364-9. PubMed ID: 23201707
[TBL] [Abstract][Full Text] [Related]
56. [Management of immune checkpoint inhibitors-induced liver toxicity in cancer].
Lebossé F; Bancel B; Levrero M; Merle P
Bull Cancer; 2020 Oct; 107(10):1056-1068. PubMed ID: 32951849
[TBL] [Abstract][Full Text] [Related]
57. [Role of total parenteral nutrition in determining liver insufficiency in patients with cranial injuries. Glucose vs glucose + lipids].
Zagara G; Locati L
Minerva Anestesiol; 1989 Dec; 55(12):509-12. PubMed ID: 2517679
[TBL] [Abstract][Full Text] [Related]
58. The administration of ghrelin improved hepatocellular injury following parenteral feeding in a rat model of short bowel syndrome.
Onishi S; Kaji T; Yamada W; Nakame K; Moriguchi T; Sugita K; Yamada K; Kawano T; Mukai M; Souda M; Yamada S; Yoshioka T; Tanimoto A; Ieiri S
Pediatr Surg Int; 2016 Dec; 32(12):1165-1171. PubMed ID: 27651372
[TBL] [Abstract][Full Text] [Related]
59. Clinical and Pathological Features of Immune Checkpoint Inhibitor-induced Liver Injury in Comparison with Drug-induced Liver Injury and Autoimmune Hepatitis.
Sunago K; Abe M; Yoshida O; Watanabe T; Nakamura Y; Imai Y; Koizumi Y; Hirooka M; Tokumoto Y; Hiasa Y
J Gastrointestin Liver Dis; 2023 Dec; 32(4):488-496. PubMed ID: 38147620
[TBL] [Abstract][Full Text] [Related]
60. Hepatotoxicity of immune checkpoint inhibitors: An evolving picture of risk associated with a vital class of immunotherapy agents.
Suzman DL; Pelosof L; Rosenberg A; Avigan MI
Liver Int; 2018 Jun; 38(6):976-987. PubMed ID: 29603856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
